November 19, 2026

Online Shop Review

Online Shop and Product Review

More than half of today's unicorn health startups haven't published any influential research — and some experts say that raises the risk of another Theranos

1 min read

More than half of today’s unicorn health startups haven’t published any influential research — and some experts say that raises the risk of another Theranos

A new study suggests that many of the highest-valued healthcare startups — from buzzy health insurance companies like Oscar to biotechs with record-breaking IPOs like Moderna — are failing to publish quality scientific research. That could put us on the brink…

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *